Article
Glycation modulates glutamatergic signalling and exacerbates Parkinson’s disease-like phenotypes
2021-08-25
Abstract excerpt
Alpha-synuclein (aSyn) is assumed to be a central player in the pathogenesis of synucleinopathies due to its accumulation in typical protein aggregates in the brain. However, it is still unclear how it contributes to neurodegeneration. Type-2 diabetes mellitus is a risk factor for Parkinson’s disease and, one common molecular alteration among these disorders is an age-associated increase in protein glycation. Thus...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3b134eaa-3c0d-5bef-9f80-db658e319d84
- DOI
- 10.1101/2021.08.24.457507
